Consortium
The international consortia turning population-scale human genetics into biology, targets, and medicines.
Modern human genetics is a team sport. No single cohort is large enough to resolve rare-variant effects or rare diseases, so the field organizes into consortia — harmonizing phenotypes, sharing summary statistics, and meta-analyzing across millions of participants. Below is a curated map of the consortia that matter most for statistical genetics, target identification, and translational drug discovery.
Rare-Variant & Sequencing Consortia
BRaVa
The Biobank Rare Variant Analysis consortium runs harmonized, gene-based rare-variant association tests across global biobanks. Using a shared phenotype dictionary and a common SAIGE-GENE+ pipeline, BRaVa meta-analyzes exome/genome sequencing to find rare coding variants driving disease — the resolution single biobanks lack.
gnomAD
The Genome Aggregation Database (successor to ExAC) is the field's reference for allele frequencies, aggregating exomes and genomes from hundreds of thousands of individuals across diverse populations. Essential for variant interpretation, constraint metrics (pLI, LOEUF), and filtering candidate disease variants.
TOPMed
NHLBI's Trans-Omics for Precision Medicine program generates deep whole-genome sequencing across diverse cohorts, powering rare-variant discovery for heart, lung, blood, and sleep traits — and underpinning one of the most widely used imputation reference panels.
Genebass
A browsable resource of gene-based and single-variant association results from UK Biobank exome sequencing (~400k participants, thousands of phenotypes). A practical entry point for exploring exome-wide rare-variant signals without re-running analyses.
Regeneron Genetics Center
Through the DiscovEHR collaboration and large-scale exome sequencing of biobank cohorts, the RGC links genetics to electronic health records at industrial scale — a model for genetics-first drug-target discovery in pharma.
Biobank Networks & Meta-Analysis
GBMI
The Global Biobank Meta-analysis Initiative is a collaborative network of biobanks spanning multiple continents and ancestries. It develops harmonized phenotype definitions and meta-analyzes GWAS across cohorts to improve power and trans-ancestry generalizability — the backbone many other efforts (including BRaVa) build on.
FinnGen
A public–private partnership combining genome data with national health registries for hundreds of thousands of Finnish participants. Finland's population history enriches otherwise-rare deleterious variants, making FinnGen exceptionally powerful for loss-of-function discovery.
Million Veteran Program
The U.S. Department of Veterans Affairs' MVP is one of the world's largest genomic cohorts linked to longitudinal EHR, with strong representation of African- and Hispanic-ancestry participants — critical for equitable, multi-ancestry genetic discovery.
All of Us
NIH's flagship precision-medicine program is enrolling a million-plus diverse U.S. participants with whole-genome sequencing, EHR, surveys, and wearables — deliberately oversampling communities historically underrepresented in research.
Genomics England
Born from the 100,000 Genomes Project, Genomics England embeds whole-genome sequencing into the NHS for rare disease and cancer, pairing clinical-grade interpretation with a research environment for discovery.
GWAS Aggregation, Catalogs & Target ID
NHGRI-EBI GWAS Catalog
The authoritative, manually curated catalog of published genome-wide association studies and their summary statistics. The starting point for any locus lookup, polygenic score, or downstream functional follow-up.
Open Targets
A partnership of EMBL-EBI, the Wellcome Sanger Institute, and pharma that integrates genetics, genomics, and chemistry to systematically score and prioritize drug targets — operationalizing the genetics-to-therapeutics pipeline.
ICDA
The International Common Disease Alliance coordinates the global community translating genetic associations for common disease into mechanism and therapeutics, setting shared roadmaps and standards across cohorts and methods.
Trait- & Disease-Specific Consortia
Psychiatric Genomics Consortium
The PGC is the largest collaboration in the history of psychiatry, meta-analyzing GWAS for schizophrenia, bipolar disorder, depression, ADHD, autism, and more — a template for how to scale genetics in complex, heterogeneous traits.
GIANT
The Genetic Investigation of ANthropometric Traits consortium defined the genetic architecture of height, BMI, and body shape across millions of individuals — landmark work on polygenicity and effect-size distributions.
CHARGE
Cohorts for Heart and Aging Research in Genomic Epidemiology unites prospective cohorts to study cardiovascular, metabolic, and aging-related phenotypes, pioneering large-scale GWAS meta-analysis design.
ENIGMA
Enhancing NeuroImaging Genetics through Meta-Analysis links brain imaging phenotypes to genetics across hundreds of institutions, mapping the genetic basis of brain structure and neuropsychiatric disease.
DIAGRAM / DIAMANTE
The diabetes genetics consortia (DIAGRAM and its trans-ancestry successor DIAMANTE) have driven type 2 diabetes locus discovery and fine-mapping across global populations, a model for ancestry-diverse GWAS.
Global Lipids Genetics Consortium
The GLGC meta-analyzes blood-lipid GWAS (LDL, HDL, triglycerides, total cholesterol) across millions of participants — work that has directly informed cardiovascular drug targets such as PCSK9.
CKDGen
The Chronic Kidney Disease Genetics consortium meta-analyzes GWAS for kidney function (eGFR), CKD, and related biomarkers across global cohorts, mapping the genetic architecture of renal disease.
Functional Genomics & Reference Resources
1000 Genomes / IGSR
The 1000 Genomes Project, now sustained by the International Genome Sample Resource, produced the first deep catalog of human variation across populations — still a workhorse reference and imputation panel.
GTEx
The Genotype-Tissue Expression project maps eQTLs and sQTLs across dozens of human tissues, providing the regulatory bridge that connects GWAS loci to genes and mechanisms.
ENCODE
The Encyclopedia of DNA Elements annotates functional elements — regulatory regions, chromatin states, transcription-factor binding — across cell types, essential for interpreting non-coding variants.
ClinGen & ClinVar
The NIH Clinical Genome Resource (ClinGen) and the ClinVar archive define and aggregate clinical variant interpretations — the shared standard for gene–disease validity and variant pathogenicity in clinical genetics.
Human Cell Atlas
An international effort to map every human cell type at single-cell resolution, building the reference that increasingly grounds where and how disease genes act.
This is a curated, non-exhaustive guide focused on consortia most relevant to statistical genetics and translational drug discovery. Membership, scale, and scope evolve continually — follow each consortium's site for current data releases and participation details.